OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
40
Results
Show all
Save search
Copy query
Show results for
Unknown
(40)
Publication Date
Release Date
2021
(8)
2025
(5)
2022
(5)
2024
(4)
2015
(4)
2023
(3)
2016
(3)
2013
(2)
2011
(2)
2026
(1)
2019
(1)
2017
(1)
2014
(1)
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
Genetic Diversity of
Puumala orthohantavirus
in Rodents and Human Patients in Austria, 2012-2019.
Not available
S-EPMC8069475
|
biostudies-literature
Cite
TriCAM (NCT02976558) - a randomized controlled pilot study of complementary medicine in allogeneic stem cell transplantation to improve quality of life.
Not available
S-EPMC12418651
|
biostudies-literature
Cite
Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV.
Not available
S-EPMC4895174
|
biostudies-literature
Cite
Student public commitment in a school-based diabetes prevention project: impact on physical health and health behavior.
Not available
S-EPMC3189889
|
biostudies-literature
Cite
Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles.
Not available
S-EPMC10192332
|
biostudies-literature
Cite
Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia - implications for the European LeukemiaNet risk classification.
Not available
S-EPMC10624615
|
biostudies-literature
Cite
Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial.
Not available
S-EPMC12824691
|
biostudies-literature
Cite
Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV.
Not available
S-EPMC4574015
|
biostudies-literature
Cite
Validation of the revised 2022 European LeukemiaNet risk stratification in adult patients with acute myeloid leukemia.
Not available
S-EPMC11960536
|
biostudies-literature
Cite
Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia - long-term follow-up with focus on younger patients.
Not available
S-EPMC11978746
|
biostudies-literature
Cite
Previous
page
1 / 4
You're on page
1
page
2
page
3
page
4
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets